BCL-2 ANATHOGENE-3 (BAG3) DILATED CARDIOMYOPATHY (DCM)

Clinical trials for BCL-2 ANATHOGENE-3 (BAG3) DILATED CARDIOMYOPATHY (DCM) explained in plain language.

Never miss a new study

Get alerted when new BCL-2 ANATHOGENE-3 (BAG3) DILATED CARDIOMYOPATHY (DCM) trials appear

Sign up with your email to follow new studies for BCL-2 ANATHOGENE-3 (BAG3) DILATED CARDIOMYOPATHY (DCM), keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Not yet finished but already full! 1

Scientists track rare genetic heart disease over three years

Knowledge-focused Ongoing

This study aims to learn how a specific genetic heart condition (BAG3 dilated cardiomyopathy) naturally changes over time. It will follow about 35 people with the condition for three years, observing their heart health through regular check-ups and tests. The goal is to gather de…

Matched conditions: BCL-2 ANATHOGENE-3 (BAG3) DILATED CARDIOMYOPATHY (DCM)

Sponsor: Alexion Pharmaceuticals, Inc. • Aim: Knowledge-focused

Last updated Apr 04, 2026 01:05 UTC

BCL-2 ANATHOGENE-3 (BAG3) DILATED CARDIOMYOPATHY (DCM)

Get alerted when new BCL-2 ANATHOGENE-3 (BAG3) DILATED CARDIOMYOPATHY (DCM) trials appear

Scientists track rare genetic heart disease over three years